EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.24 | fumonisin B1 | complete inhibition in vivo and in vitro | Rattus norvegicus | |
2.3.1.24 | additional information | fumonisins isolated from Fusarium moniliforme inhibit the conversion of sphinganine to N-acyl-sphinganines and the activity of sphingosine N-acyltransferase (ceramide synthase). No inhibiton of serine palmitoyltransferase by fumonisin B1 | Rattus norvegicus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.3.1.24 | microsome | - |
Rattus norvegicus | - |
- |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.24 | sphingosine + palmitoyl-CoA | Rattus norvegicus | - |
N-palmitoylsphingosine + CoA | - |
? | |
2.3.1.24 | sphingosine + palmitoyl-CoA | Rattus norvegicus Sprague-Dawley | - |
N-palmitoylsphingosine + CoA | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.24 | Rattus norvegicus | - |
- |
- |
2.3.1.24 | Rattus norvegicus Sprague-Dawley | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.3.1.24 | hepatocyte | - |
Rattus norvegicus | - |
2.3.1.24 | liver | - |
Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.24 | additional information | the conversion of [14C]sphinganine to N-acyl-[14C]sphinganines | Rattus norvegicus | ? | - |
? | |
2.3.1.24 | additional information | the conversion of [14C]sphinganine to N-acyl-[14C]sphinganines | Rattus norvegicus Sprague-Dawley | ? | - |
? | |
2.3.1.24 | sphingosine + palmitoyl-CoA | - |
Rattus norvegicus | N-palmitoylsphingosine + CoA | - |
? | |
2.3.1.24 | sphingosine + palmitoyl-CoA | - |
Rattus norvegicus Sprague-Dawley | N-palmitoylsphingosine + CoA | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.24 | ceramide synthase | - |
Rattus norvegicus |
2.3.1.24 | sphingosine N-acyltransferase | - |
Rattus norvegicus |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.3.1.24 | 37 | - |
assay at | Rattus norvegicus |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.3.1.24 | 7.4 | - |
assay at | Rattus norvegicus |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.3.1.24 | 0.0001 | - |
pH 7.4, 37°C | Rattus norvegicus | fumonisin B1 |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.3.1.24 | malfunction | disruption of the de novo pathway of sphingolipid biosynthesis may be a critical in the diseases that have been associated with consumption of fumonisins. Fusarium moniliforme causes equine leucoencephalomalacia, porcine pulmonary edem syndrome, and liver cancer in rats | Rattus norvegicus |
2.3.1.24 | metabolism | the conversion of sphinganine to N-acyl-sphinganines is thought to precede via introduction of the 4,5-trans double bond of sphingosine | Rattus norvegicus |